Success Metrics

Clinical Success Rate
97.2%

Based on 70 completed trials

Completion Rate
97%(70/72)
Active Trials
0(0%)
Results Posted
1%(1 trials)
Terminated
2(3%)

Phase Distribution

Ph phase_4
3
4%
Ph phase_1
8
10%
Ph phase_3
12
15%
Ph not_applicable
27
34%
Ph phase_2
30
38%

Phase Distribution

8

Early Stage

30

Mid Stage

15

Late Stage

Phase Distribution80 total trials
Phase 1Safety & dosage
8(10.0%)
Phase 2Efficacy & side effects
30(37.5%)
Phase 3Large-scale testing
12(15.0%)
Phase 4Post-market surveillance
3(3.8%)
N/ANon-phased studies
27(33.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.6%

70 of 74 finished

Non-Completion Rate

5.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

80

all time

Status Distribution
Completed(70)
Terminated(4)
Other(6)

Detailed Status

Completed70
unknown5
Withdrawn2
Terminated2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
80
Active
0
Success Rate
97.2%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (10.0%)
Phase 230 (37.5%)
Phase 312 (15.0%)
Phase 43 (3.8%)
N/A27 (33.8%)

Trials by Status

withdrawn23%
completed7088%
terminated23%
unknown56%
suspended11%

Recent Activity

Clinical Trials (80)

Showing 20 of 80 trialsScroll for more
NCT00003008Phase 2

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Completed
NCT00001084Phase 2

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Completed
NCT00001095Phase 2

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Completed
NCT00001083Phase 2

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Completed
NCT00000848Phase 2

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Completed
NCT00000841Phase 3

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Completed
NCT00027339Phase 2

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Completed
NCT00001058Phase 2

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Completed
NCT00012519Phase 1

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Completed
NCT00006339Phase 2

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Withdrawn
NCT00001086Phase 2

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Completed
NCT00039975Phase 1

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Completed
NCT00005762Not Applicable

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Completed
NCT00001133Phase 1

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Completed
NCT00000912Phase 2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed
NCT00000914Not Applicable

A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Completed
NCT00000944Phase 1

A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Completed
NCT00000859Not Applicable

A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Completed
NCT00000896Not Applicable

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Completed
NCT00000877Phase 1

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

Completed

Drug Details

Intervention Type
DRUG
Total Trials
80